Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.23 -0.27 (-2.57%)
As of: Nov 11, 2026 · 12:40 PM EST

Monte Rosa Therapeutics (GLUE) Return on Assets [ROA] (2021 - 2026)

Updated

Monte Rosa Therapeutics (GLUE) reported Return on Assets [ROA] of -22.58% for Q2 2026, down 29.00 percentage points from 6.42% a year earlier and down 0.63 percentage points from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Monte Rosa Therapeutics posted Return on Assets [ROA] of -8.71%, up 10.88 percentage points from FY2024.

  • Return on Assets [ROA] has a four-year change of +26.36 percentage points (FY2021 to FY2025).
  • By year, Return on Assets [ROA] came in at -19.58% in FY2024 (+22.31 pp), -41.90% in FY2023 (-11.28 pp), -30.62% in FY2022 (+4.45 pp) and -35.06% in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Assets [ROA] since Q3 2024.
  • Year over year, Return on Assets [ROA] gained in six of the last eight quarters, with an average year-over-year change of +17.62 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2025 (a gain of 49.13 percentage points); the low point was Q2 2026 (a drop of 29.00 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -21.95% (Q1 2026), -8.50% (Q4 2025) and 5.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Monte Rosa Therapeutics 897.23 Mn 472.20 Mn - -19.14%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -19.14%
Jun 30, 2026 -22.82%
Mar 31, 2026 -22.18%
Dec 31, 2025 -8.61%
Sep 30, 2025 4.89%
Jun 30, 2025 6.23%
Mar 31, 2025 1.33%
Dec 31, 2024 -19.46%
Sep 30, 2024 -36.49%
Jun 30, 2024 -43.04%
Mar 31, 2024 -47.88%
Dec 31, 2023 -49.05%
Sep 30, 2023 -49.64%
Jun 30, 2023 -42.37%
Mar 31, 2023 -35.57%
Dec 31, 2022 -30.92%
Sep 30, 2022 -28.18%
Jun 30, 2022 -26.64%
Mar 31, 2022 -24.38%
Dec 31, 2021 -19.97%
API Access

Monte Rosa Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GLUE&period=max&api_key=YOUR_API_KEY